Geoff Brown

Dr. Geoff Brown

Department of Chemistry, The University of Reading, Whiteknights, Reading, RG6 6AD, UK

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2010 in Molecules
Verified
Journal Article
Open access
PDF file
GBGeoff Brown
Geoff Brown
The Chinese medicinal plant Artemisia annua L. (Qinghao) is the only known source of the sesquiterpene artemisinin (Qinghaosu), which is used in the treatment of malaria. Artemisinin is a highly oxygenated sesquiterpene, containing a unique 1,2,4-trioxane ring structure, which is responsible for the antimalarial activity of this natural product. The phytochemistry of A. annua is dominated by both sesquiterpenoids and flavonoids, as is the case for many other plants in the Asteraceae family. However, A. annua is distinguished from the other members of the family both by the very large number of natural products which have been characterised to date (almost six hundred in total, including around fifty amorphane and cadinane sesquiterpenes), and by the highly oxygenated nature of many of the terpenoidal secondary metabolites. In addition, this species also contains an unusually large number of terpene allylic hydroperoxides and endoperoxides. This observation forms the basis of a proposal that the biogenesis of many of the highly oxygenated terpene metabolites from A. annua – including artemisinin itself – may proceed by spontaneous oxidation reactions of terpene precursors, which involve these highly reactive allyllic hydroperoxides as intermediates. Although several studies of the biosynthesis of artemisinin have been reported in the literature from the 1980s and early 1990s, the collective results from these studies were rather confusing because they implied that an unfeasibly large number of different sesquiterpenes could all function as direct precursors to artemisinin (and some of the experiments also appeared to contradict one another). As a result, the complete biosynthetic pathway to artemisinin could not be stated conclusively at the time. Fortunately, studies which have been published in the last decade are now providing a clearer picture of the biosynthetic pathways in A. annua. By synthesising some of the sesquiterpene natural products which have been proposed as biogenetic precursors to artemisinin in such a way that they incorporate a stable isotopic label, and then feeding these precursors to intact A. annua plants, it has now been possible to demonstrate that dihydroartemisinic acid is a late-stage precursor to artemisinin and that the closely related secondary metabolite, artemisinic acid, is not (this approach differs from all the previous studies, which used radio-isotopically labelled precursors that were fed to a plant homogenate or a cell-free preparation). Quite remarkably, feeding experiments with labeled dihydroartemisinic acid and artemisinic acid have resulted in incorporation of label into roughly half of all the amorphane and cadinane sesquiterpenes which were already known from phytochemical studies of A. annua. These findings strongly support the hypothesis that many of the highly oxygenated sesquiterpenoids from this species arise by oxidation reactions involving allylic hydroperoxides, which seem to be such a defining feature of the chemistry of A. annua. In the particular case of artemisinin, these in vivo results are also supported by in vitro studies, demonstrating explicitly that the biosynthesis of artemisinin proceeds via the tertiary allylic hydroperoxide, which is derived from oxidation of dihydroartemisinic acid. There is some evidence that the autoxidation of dihydroartemisinic acid to this tertiary allylic hydroperoxide is a non-enzymatic process within the plant, requiring only the presence of light; and, furthermore, that the series of spontaneous rearrangement reactions which then convert this allylic hydroperoxide to the 1,2,4-trioxane ring of artemisinin are also non-enzymatic in nature.

1 September 2003 in Phytochemistry
Verified
Journal Article
Closed access
GBGeoff Brown
Geoff Brown
GLGuang-Yi Liang
Guang-Yi Liang
LSLai-King Sy
Lai-King Sy

29 May 2012 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
JBJohn Brazier
John Brazier
ASArti Shah
Arti Shah
GBGeoff Brown
Geoff Brown
I-motif formation has been confirmed in a number of gene promoter sequences known to form G-quadruplex structures. I-motif formation can occur close to physiological temperature and pH for h-tert and PDGF-A. The i-motif structure formed by a HIF-1α promoter sequence shows unexpected stability near neutral pH.

1 August 2014 in The Plant Cell
Verified
Journal Article
Open access
PDF file
AKAndrew J. King
Andrew J. King
GBGeoff Brown
Geoff Brown
AGAlison D. Gilday
Alison D. Gilday
TLTony Larson
Tony Larson
IGIan A. Graham
Ian A. Graham
The Euphorbiaceae produce a diverse range of diterpenoids, many of which have pharmacological activities. These diterpenoids include ingenol mebutate, which is licensed for the treatment of a precancerous skin condition (actinic keratosis), and phorbol derivatives such as resiniferatoxin and prostratin, which are undergoing investigation for the treatment of severe pain and HIV, respectively. Despite the interest in these diterpenoids, their biosynthesis is poorly understood at present, with the only characterized step being the conversion of geranylgeranyl pyrophosphate into casbene. Here, we report a physical cluster of diterpenoid biosynthetic genes from castor (Ricinus communis), including casbene synthases and cytochrome P450s from the CYP726A subfamily. CYP726A14, CYP726A17, and CYP726A18 were able to catalyze 5-oxidation of casbene, a conserved oxidation step in the biosynthesis of this family of medicinally important diterpenoids. CYP726A16 catalyzed 7,8-epoxidation of 5-keto-casbene and CYP726A15 catalyzed 5-oxidation of neocembrene. Evidence of similar gene clustering was also found in two other Euphorbiaceae, including Euphorbia peplus, the source organism of ingenol mebutate. These results demonstrate conservation of gene clusters at the higher taxonomic level of the plant family and that this phenomenon could prove useful in further elucidating diterpenoid biosynthetic pathways.

1 September 2007 in Tetrahedron
Verified
Journal Article
Closed access
GBGeoff Brown
Geoff Brown
LSLai-King Sy
Lai-King Sy

7 December 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TCTomasz Czechowski
Tomasz Czechowski
TLTony R. Larson
Tony R. Larson
TCTheresa M. Catania
Theresa M. Catania
DHDavid Harvey
David Harvey
GBGeoff Brown
Geoff Brown
IGIan A. Graham
Ian A. Graham
Significance: The antimalarial artemisinin is a sesquiterpene lactone produced by glandular secretory trichomes on the leaves of Artemisia annua . Using a mutant impaired in artemisinin synthesis, we demonstrate the importance of nonenzymatic conversions in terpenoid metabolism and highlight the ability of A. annua glandular secretory trichomes to redirect flux into a sesquiterpene epoxide. The research presented offers insight into the mechanism of the final steps of artemisinin synthesis in A. annua , with significant implications for future production of secondary compounds in native versus heterologous host systems.